Ocular Therapeutix
OCUL
OCUL
73 hedge funds and large institutions have $170M invested in Ocular Therapeutix in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 18 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
73
Holders Change
-3
Holders Change %
-3.95%
% of All Funds
1.82%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
12
Increased
29
Reduced
18
Closed
10
Calls
$2.98M
Puts
$1.5M
Net Calls
+$1.48M
Net Calls Change
+$848K
Top Buyers
| 1 |
BlackRock
New York
|
+$12M |
| 2 |
CCI
Columbus Circle Investors
|
+$5.73M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$4.24M |
| 4 |
JPMorgan Chase & Co
New York
|
+$3.39M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$3.17M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Millennium Management
New York
| – | -$530K | -63,370 | Closed |
|
77
Squarepoint
New York
| – | -$510K | -60,985 | Closed |
|
|
TI
78
Trexquant Investment
Stamford,
Connecticut
| – | -$181K | -21,663 | Closed |
|
|
PP
79
Paloma Partners
Greenwich,
Connecticut
| – | -$109K | -13,023 | Closed |
|
80
Simplex Trading
Chicago,
Illinois
| – | -$96K | -11,557 | Closed |
|
|
AIM
81
Acrospire Investment Management
Chicago,
Illinois
| – | -$51K | -6,056 | Closed |
|
82
Walleye Trading
New York
| – | -$2K | -200 | Closed |
|
|
TDC
83
Thompson Davis & Co
Richmond,
Virginia
| – | -$1K | -125 | Closed |
|